Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical is a research and development-oriented pharmaceutical company with a focus on innovative drugs, especially biopharmaceuticals. In collaboration with Roche, it aims to generate continuous innovation to provide patients with advanced medical solutions. The company emphasizes patient-centric healthcare, sustainability, open innovation, and digital transformation as key drivers of its growth and societal contribution.
Industries
Nr. of Employees
Very Large (1000+)
Chugai Pharmaceutical Co., Ltd.
Products
Next‑generation biologics drug substance manufacturing facility
A biologics drug substance manufacturing facility designed to support large‑scale production with emphasis on safety, speed, and sustainability.
Integrated R&D discovery platforms
Platforms supporting antibody, mid‑size molecule (cyclic peptide), and small‑molecule discovery to generate differentiated therapeutic candidates.
Next‑generation biologics drug substance manufacturing facility
A biologics drug substance manufacturing facility designed to support large‑scale production with emphasis on safety, speed, and sustainability.
Integrated R&D discovery platforms
Platforms supporting antibody, mid‑size molecule (cyclic peptide), and small‑molecule discovery to generate differentiated therapeutic candidates.
Services
Open innovation and partnering programs
Collaborative programs to co‑develop drug candidates and share discovery platforms with academic institutions, startups, and external research organizations.
Digital transformation and AI research collaborations
Research collaborations and internal initiatives applying AI, generative AI, real‑world data, and digital biomarkers to improve drug discovery and clinical development processes.
Science education facility (BioLab) for K‑12
On‑site science education facility offering experimental classes and programs for elementary to high school students to increase interest in biology and biotechnology.
Digital transformation events and advisory
Events, workshops, and advisory activities to share digital strategy, showcase digital solutions, and engage internal and external stakeholders in digital initiatives.
Open innovation and partnering programs
Collaborative programs to co‑develop drug candidates and share discovery platforms with academic institutions, startups, and external research organizations.
Digital transformation and AI research collaborations
Research collaborations and internal initiatives applying AI, generative AI, real‑world data, and digital biomarkers to improve drug discovery and clinical development processes.
Science education facility (BioLab) for K‑12
On‑site science education facility offering experimental classes and programs for elementary to high school students to increase interest in biology and biotechnology.
Digital transformation events and advisory
Events, workshops, and advisory activities to share digital strategy, showcase digital solutions, and engage internal and external stakeholders in digital initiatives.
Expertise Areas
- Antibody engineering
- Mid‑size molecule discovery (cyclic peptides)
- Small‑molecule drug discovery
- Bioprocess development and biologics manufacturing
Key Technologies
- Antibody engineering
- Bispecific antibody formats
- Conditionally activated antibody formats
- Cyclic peptide technologies